NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00705874 2016-07-21Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaProgen PharmaceuticalsPhase 1 Completed172 enrolled 13 charts
NCT01602289 2015-06-08A Study of LY2875358 in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed17 enrolled